SEI INVESTMENTS CO - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 52 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q1 2022$405,000
+5.2%
309,0000.0%0.00%0.0%
Q4 2021$385,000
-6.1%
309,0000.0%0.00%0.0%
Q3 2021$410,000
-0.7%
309,0000.0%0.00%0.0%
Q2 2021$413,000
-0.5%
309,0000.0%0.00%0.0%
Q1 2021$415,000
+24.6%
309,000
+28.2%
0.00%0.0%
Q4 2020$333,000
+51.4%
241,000
+50.6%
0.00%0.0%
Q3 2020$220,000
-17.3%
160,0000.0%0.00%0.0%
Q2 2020$266,000
+29.8%
160,0000.0%0.00%0.0%
Q1 2020$205,000
-16.3%
160,0000.0%0.00%0.0%
Q4 2019$245,000
+11.9%
160,0000.0%0.00%0.0%
Q3 2019$219,000
+4.3%
160,0000.0%0.00%0.0%
Q2 2019$210,000
-53.0%
160,000
-51.7%
0.00%
-50.0%
Q1 2019$447,000
+120.2%
331,000
+178.2%
0.00%
+100.0%
Q4 2018$203,0000.0%119,0000.0%0.00%0.0%
Q3 2018$203,000
-31.4%
119,000
-42.0%
0.00%0.0%
Q2 2018$296,000205,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q2 2019
NameSharesValueWeighting ↓
Myriad Asset Management Ltd. 17,500,000$29,890,0004.31%
SSI INVESTMENT MANAGEMENT LLC 8,987,000$15,319,0001.18%
CSS LLC/IL 14,955,000$25,561,0001.09%
SHENKMAN CAPITAL MANAGEMENT INC 3,983,000$6,799,0000.82%
Verition Fund Management LLC 6,425,000$10,968,0000.39%
ADVENT CAPITAL MANAGEMENT /DE/ 9,495,000$16,214,0000.33%
MACKAY SHIELDS LLC 21,609,000$36,877,0000.28%
WOLVERINE ASSET MANAGEMENT LLC 12,776,000$21,819,0000.25%
Calamos Advisors LLC 24,100,000$41,405,0000.23%
OAKTREE CAPITAL MANAGEMENT LP 8,895,000$15,184,0000.20%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders